Long‐term clinical and endoscopic outcomes of ustekinumab in pediatric Crohn's disease with anti‐tumor necrosis factor failure
Ustekinumab appeared effective in maintaining long-term clinical remission with endoscopic improvement in pediatric-onset Crohn's disease with anti-tumor necrosis factor failure.
Authors
- Satoru Nagata (ORCID: https://orcid.org/0000-0002-2319-0885)
- Yoko Yamamoto (ORCID: https://orcid.org/0000-0001-9953-6523)
- Hirotaka Shimizu (ORCID: https://orcid.org/0000-0001-7173-0420)
- Eri Miyata (ORCID: https://orcid.org/0000-0001-8229-5866)
- Katsuhiro Arai (ORCID: https://orcid.org/0000-0002-6440-4640)
- Ichiro Takeuchi (ORCID: https://orcid.org/0000-0003-2198-913X)
- Hiroki Fujikawa (ORCID: https://orcid.org/0000-0002-4297-9881)
- Hiroaki To (ORCID: https://orcid.org/0009-0008-3798-4935)
- Masanori Toda (ORCID: https://orcid.org/0009-0004-7905-6118)
Institutions
- Hiroshima University (JP)
- Juntendo University (JP)
- National Center For Child Health and Development (JP)
- Tokyo Women's Medical University (JP)
Publication Details
- Journal
- Journal of Gastroenterology and Hepatology
- Published
- 2024-11-04
- DOI
- https://doi.org/10.1111/jgh.16790
- Citations
- 1
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.55
Funders
- Ministry of Health, Labour and Welfare